Skip to main content
GUANGZHOU JET BIO-FILTRATION CO.,LTD logo

GUANGZHOU JET BIO-FILTRATION CO.,LTD — Investor Relations & Filings

Ticker · 688026 ISIN · CNE100003RQ9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 842 across all filing types
Latest filing 2026-05-14 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688026

About GUANGZHOU JET BIO-FILTRATION CO.,LTD

https://www.jetbiofil.com/

Guangzhou Jet Bio-Filtration Co., Ltd. specializes in the research, development, manufacturing, and distribution of high-quality laboratory consumables. The company provides a comprehensive range of products primarily focused on cell culture, liquid handling, filtration, and sample storage. Key offerings include cell culture flasks, dishes, and plates, as well as serological pipettes, centrifuge tubes, and vacuum filtration systems. Utilizing advanced manufacturing technologies and Class 100,000 cleanroom facilities, the company ensures products meet international quality standards, including ISO 9001 and ISO 13485. Its solutions serve diverse sectors such as biotechnology, pharmaceuticals, clinical diagnostics, and academic research. The company is recognized for its commitment to innovation and precision, providing reliable tools for life science laboratories worldwide.

Recent filings

Filing Released Lang Actions
关于回购公司股份比例达到1%暨回购进展的公告
Transaction in Own Shares Classification · 91% confidence The document is an official announcement detailing the progress of the company’s share repurchase plan, including total shares repurchased, percentage of total share capital, amounts, and prices. This clearly falls under a transaction in own shares (share buyback) disclosure rather than a financial report or regulatory certification. Thus, it should be classified as POS (Transaction in Own Shares).
2026-05-14 Chinese
广州洁特生物过滤股份有限公司向不特定对象发行可转换公司债券受托管理事务报告（2025年度）
Regulatory Filings Classification · 85% confidence The document is a trustee management affairs report (“受托管理事务报告”) for the company’s 2025 convertible bond issuance. It is not the company’s full annual report, earnings release, board change notice, or a call transcript. Instead, it is a regulatory compliance report detailing bond terms, trustee duties, use of proceeds, and related financial updates under the “Convertible Bond Management Measures.” Since no specific category covers a trustee management report and it is a regulatory filing, it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-12 Chinese
2025年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2025年度董事会审计委员会履职情况报告" which translates to "2025 Board Audit Committee Performance Report." It details the audit committee's activities, meetings, supervision of financial reports, external audit work, internal controls, and compliance with regulations during the 2025 fiscal year. The document does not contain actual financial statements or detailed financial data but rather a summary and evaluation of the audit committee's duties and oversight. It is a report on the audit committee's performance and oversight activities rather than a full audit report or annual report. Given the focus on audit committee activities and oversight, this fits best under the category of Audit Report / Information (AR), which includes audit reports and related information excluding full annual reports. The document length is 2731 characters, which is relatively short but contains substantive content about audit committee work, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2025
2026-04-29 Chinese
2025年度非经营性资金占用及其他关联资金往来情况表
Audit Report / Information Classification · 100% confidence The document is a specialized audit report titled "关于广州洁特生物过滤股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告" which translates to a special audit report on non-operating fund occupation and other related party fund transactions for the year 2025. It includes an audit opinion from a registered accounting firm, references to regulatory guidelines for listed companies, and detailed financial tables related to fund occupation and related party transactions. The document is not a full annual report but a standalone audit report focusing on a specific financial aspect. It contains actual audit findings and detailed financial data, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2025
2026-04-29 Chinese
2025年年度审计报告
Audit Report / Information Classification · 100% confidence The document contains an extensive audit report including an auditor's opinion, detailed financial statements (consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and equity changes), and notes to the financial statements. It also includes the auditor's responsibilities, key audit matters, and certification by the auditors. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and audit opinions confirms this is a standalone audit report. Therefore, the document fits the category of Audit Report / Information (AR). FY 2025
2026-04-29 Chinese
2025年度募集资金存放、管理与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the 2025 annual usage, management, and storage of funds raised through a convertible bond issuance by Guangzhou Jiete Biological Filtration Co., Ltd. It includes specifics on the amount raised, fees, net proceeds, usage during the year, cash management, bank accounts, project investment progress, and compliance with regulatory requirements. It also contains auditor and sponsor opinions on the fund usage and management, as well as detailed tables of fund usage and project progress. The document is titled as a "专项报告" (special report) on the annual usage of raised funds, which aligns with a specialized report on capital raising and fund usage rather than a general annual report or earnings release. The content focuses on the management and actual use of raised capital, consistent with a Capital/Financing Update filing. It is not a full annual report (10-K), audit report, or earnings release, nor is it a simple announcement or certification. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2026-04-29 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.